BioHealth News Archive
Useful Stats: Initial Public Offering (IPO) totals and trends from fiscal years 2019-2022 | SSTI
Over the past four fiscal years, there have been 1,977 initial public offerings (IPOs) completed by companies headquartered in the U.S., according to PitchBook,…
Read More
United Therapeutics CEO Martine Rothblatt Aims to Print Organs
After creating the satellite-radio industry and developing a drug for her daughter's serious disease, Martine Rothblatt is leading her biotech to test another boundary…
Read More
Therapeutic Developments and Innovative Strategies in Oncology: An Expert Discussion
Cancer continues to be a leading cause of mortality worldwide, accounting for nearly 10 million deaths in 2020. Alongside growing incidence rates each year,…
Read More
OUR QUANTUM FUTURE: SOME ASSEMBLY REQUIRED A COLLABORATIVE APPROACH FOR ETHICS, POLICY, AND STANDARDS — Quantum World Congress
There is a new revolution of technology emerging based on the understanding of sub-atomic physics: quantum. This revolution leverages advanced scientific understanding and engineering…
Read More
I-Corps at NIH – Funding Opportunity Announcement PAR-22-073
You’ve Created the Technology. Put It to Work with I-Corps. I-Corps at NIH is an entrepreneurship training program specifically designed for companies that received…
Read More
Montgomery County Council Passes Bill to Enhance Support for Small Businesses Engaged in Research and Development
Expedited Bill 31-22 will alter eligibility requirements of the Small Business Innovation Research and Small Business Technology Transfer Matching Grant Program ROCKVILLE, Md., Nov.…
Read More
Polaris Genomics Seeks to Reveal Invisible Wounds
Illumina Accelerator alum Polaris Genomics is investigating how genomics can help diagnose post-traumatic stress disorder (PTSD) and other mental health issues. The Maryland-based company…
Read More
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy | Business Wire
SANTA MONICA, Calif. & AMSTERDAM--(BUSINESS WIRE)--Neogene Therapeutics, Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor…
Read More
NIH Wins Licensing Executive Society Deals of Distinction Award for WHO C-TAP Partnership | Technology Transfer
The NIH Technology Transfer Program has won the Licensing Executive Society’s Deals of Distinction award for 2022. The Deals of Distinction Award is given…
Read More
Montgomery County and BioHealth Innovation, Inc. welcome Luis Gutierrez as an “Executive in Residence” to Help Grow County’s Biotech Industry (Updated 11/29)
Updated 11/29 BioHealth Innovation, Inc. (BHI) and Montgomery County are pleased to announce the selection of Luis Gutierrez as a part-time “Executive in Residence”—a…
Read More
Announcing Your 3rd Annual BioBuzz Awards Finalists · BioBuzz
We’re excited to announce this year’s finalists for the third annual 2022 BioBuzz Awards. These awards celebrate the people and companies across our regional community…
Read More
Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed
Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type…
Read More
Haystack Oncology Inks Lease In Baltimore’s City Garage
Biotechnology firm Haystack Oncology Inc. has signed a lease in the City Garage Science & Technology Center at the recently rebranded Baltimore Peninsula mixed-use development. Haystack, which describes itself…
Read More
QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance | Business Wire
HILDEN, Germany & GERMANTOWN, Maryland--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the monkeypox (MPXV) test for its…
Read More
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of…
Read More